CARUSO JAMES V 4
4 · Cellectar Biosciences, Inc. · Filed Jan 27, 2022
Insider Transaction Report
Form 4
CARUSO JAMES V
DirectorPresident and CEO
Transactions
- Award
Stock option (right to buy)
2022-01-25+1,419,000→ 1,419,000 totalExercise: $0.55Exp: 2032-01-25→ Common Stock (1,419,000 underlying)
Footnotes (1)
- [F1]This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date.